Cardiology

As congenital heart patients transition from pediatric care to adult care there is a world of new challenges awaiting them. How they approach those challenges and how their doctors help them in that time can determine how they manage the condition in the future.

Treatment of adult congenital heart disease has improved by leaps and bounds in the past few decades but there is still much more work to be done. Areas of research like stem cells could be part of the future of treating this condition in the future.

A lot has been done to bolster the treatment of congenital heart disease and managing the risks of this patient population. Because of that these patients are able to live a longer and fuller life including pregnancy and childbirth like other people.

Even the most severe cases of congenital heart disease can be treated to a level where they can safely navigate high risk pregnancies.

It was not that long ago that women with congenital heart disease were discouraged from becoming pregnant. Thanks to advances in diagnosis and treatment that is no longer the case.

Researchers found that as-needed use of novel oral anticoagulants can effectively lower stroke risk in “motivated†patients with atrial fibrillation.

An analysis of population-based medical databases has found that strokes are more likely to prove fatal in diabetic patients who use selective serotonin reuptake inhibitors (SSRIs) than in diabetic patients who do not.

The last several days in San Francisco have been quite busy. Nearly 15,000 international and national heart rhythm specialists had gathered to share important innovations and treatments for patients suffering from heart disease.

Men diagnosed with multiple sclerosis often have higher blood pressure than women, in addition to higher levels of diabetes, epilepsy, depression, and anxiety.

Researchers warn that non-steroidal anti-inflammatory drugs (NSAIDs) are more dangerous than previously thought, and should be prescribed with great care among patients with heart disease.

Researchers have concluded that there is a small but significant genetic component to the observed connection between high body mass index (BMI) and psoriasis.

A new trial has found that 8 weeks on a very low-calorie diet can reverse all signs of type 2 diabetes mellitus (T2DM) in many patients for at least 6 months.

A retrospective analysis of Swedish cohort data indicates that warfarin is effective enough to remain a valid alternative to novel oral anticoagulants in patients with atrial fibrillation.

“Physicians should advise patients to limit animal products when possible and consume more plants than meat,†a team of doctors from the Mayo Clinic in Arizona announced in a statement.

This year at HRS, there has been a huge focus placed on social media and the power of communication within the digital space.

This year’s Heart Rhythm Society’s (HRS) Annual Scientific Sessions in San Francisco promise to provide attendees with lots of variety and opportunities for engagement – both in person as well as in the digital sphere.

Sometimes things we enjoy cause harm, and our career can be one of those things....how do you make sense of that?

For obese patients, bariatric surgery may decrease life threatening heart failure incidents, according to research published in the Journal of the American College of Cardiology.

Another month has come and gone, and April’s best health stories are right up there with the ones from February and March. Check out the top selections made by the editors at MD Magazine.

Diets high in fat may increase the likelihood that intestinal lining cells become cancerous, according to findings published in the journal Nature.

Researchers had long believed statins decreased patients’ risk of colorectal cancer (CRC); however, new research suggests cholesterol levels are the true driver of CRC risk.

As the risk of a stroke increases with age so does the importance of monitoring patients over the course of their later years.

A trial of patients undergoing radiofrequency catheter ablation found that 90 days of postoperative antiarrhythmic drugs reduces the short-term — but not the long-term — rate of recurrent atrial fibrillation.